The future of induction chemotherapy for head and neck squamous cell carcinoma
✍ Scribed by Missak Haigentz Jr; Ezra E.W. Cohen; Gregory T. Wolf; Primož Strojan; Avraham Eisbruch; Alfio Ferlito
- Book ID
- 119339311
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 149 KB
- Volume
- 48
- Category
- Article
- ISSN
- 1368-8375
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Fifty‐one patients (32 previously untreated, 19 previously treated) with advanced squamous cell carcinoma of the head and neck received a single course of combination chemotherapy consisting of high dose __cis__‐platinum (DDP), bleomycin (Bleo), ± high dose methotrexate (MTX). Thirty‐th
To determine the efficacy of adjuvant chemotherapy in patients with advanced head and neck squamous carcinoma, the National Cancer Insitute initiated a multi-institutional, prospective randomized trial termed the Head and Neck Contracts Program. Between 1978 and 1982,462 patients with resectable Sta